942 related articles for article (PubMed ID: 17958845)
1. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
2. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
3. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
4. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
5. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
7. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
8. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
10. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
Kanwar AJ; Dogra S; Parsad D; Kumar B
Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
[TBL] [Abstract][Full Text] [Related]
11. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
El Mofty M; Mostafa W; Esmat S; Youssef R; Azzam O; Hunter N; El Hanafi G; Fawzi M
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vitiligo with broadband ultraviolet B and vitamins.
Don P; Iuga A; Dacko A; Hardick K
Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
[TBL] [Abstract][Full Text] [Related]
14. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
15. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
16. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
17. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
18. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
[TBL] [Abstract][Full Text] [Related]
19. Photo(chemo)therapy for vitiligo.
Pacifico A; Leone G
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
